From June 2024, Anna Orosz has been appointed as Director of Corporate Affairs and Communication at HEINEKEN Hungária Breweries Plc. Over the past fifteen years, she has gained extensive experience in the field of corporate communications at Egis Pharmaceuticals, Lufthansa Systems,and Bristol Myers Squibb, among others.
Anna Orosz was appointed as the new Director of Corporate Affairs and Communication at HEINEKEN Hungária Zrt. from June 1. She started her career as a cultural journalist and during her career, she has been responsible for implementing several outstanding internal and external communication projects in the field of corporate communications and employer branding as well.
During her time at Egis Pharmaceuticals, her communication responsibilities included putting together the company's first CSR report, as well as full project management of a multimedia exhibition at the Egis Science and Technology Center that showcased the entire process of pharmaceutical research and development. At Lufthansa Systems, she was also responsible for developing the company's employer branding strategy, and in recent years, she has worked on award-winning disease awareness and educational campaigns as Corporate Affairs & Patient Advocacy Manager at Bristol Myers Squibb, one of the world's leading biopharmaceutical companies.
"I’m delighted to join the HEINEKEN Hungária team during the festival season, the most exciting period for our iconic brands. Already within my first two months I’ve gained unforgettable memories and invaluable experiences, and I am also proud to play my part in further supporting the company's inspirational and socially impactful goals", Anna Orosz said.


Leave a Reply Cancel reply
Ad
Top 5 Articles
L'Oréal Appoints New Managing Director in the Region January 6, 2025
Chimborazo February 14, 2025
Gedeon Richter to Sell Chinese Biosimilar Product in Europe October 9, 2024
2024 Sustainable Future Awards Presented October 10, 2024
New President at the American Chamber of Commerce December 11, 2024
No comment yet. Be the first!